A detailed history of Range Financial Group LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Range Financial Group LLC holds 2,758 shares of GILD stock, worth $259,114. This represents 0.32% of its overall portfolio holdings.

Number of Shares
2,758
Previous 8,012 65.58%
Holding current value
$259,114
Previous $549,000 57.92%
% of portfolio
0.32%
Previous 0.28%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$66.59 - $83.99 $349,863 - $441,283
-5,254 Reduced 65.58%
2,758 $231,000
Q2 2024

Aug 02, 2024

SELL
$63.15 - $72.88 $317,076 - $365,930
-5,021 Reduced 38.53%
8,012 $549,000
Q1 2024

Apr 12, 2024

BUY
$71.58 - $87.29 $260,121 - $317,211
3,634 Added 38.66%
13,033 $954,000
Q4 2023

Jan 10, 2024

SELL
$73.27 - $83.09 $6,960 - $7,893
-95 Reduced 1.0%
9,399 $761,000
Q3 2023

Oct 10, 2023

SELL
$73.94 - $80.67 $18,928 - $20,651
-256 Reduced 2.63%
9,494 $711,000
Q2 2023

Jul 18, 2023

SELL
$76.01 - $86.7 $300,087 - $342,291
-3,948 Reduced 28.82%
9,750 $751,000
Q1 2023

Apr 03, 2023

SELL
$77.31 - $88.08 $71,357 - $81,297
-923 Reduced 6.31%
13,698 $1.14 Million
Q4 2022

Jan 13, 2023

SELL
$62.32 - $89.47 $88,182 - $126,600
-1,415 Reduced 8.82%
14,621 $0
Q3 2022

Oct 13, 2022

BUY
$59.54 - $68.01 $535 - $612
9 Added 0.06%
16,036 $989,000
Q2 2022

Jul 11, 2022

SELL
$57.72 - $65.01 $12,871 - $14,497
-223 Reduced 1.37%
16,027 $991,000
Q1 2022

May 18, 2022

BUY
$57.92 - $72.58 $79,524 - $99,652
1,373 Added 9.23%
16,250 $966,000
Q4 2021

Jul 11, 2022

SELL
$64.88 - $73.64 $2,011 - $2,282
-31 Reduced 0.21%
14,877 $1.08 Million
Q3 2021

Jul 11, 2022

BUY
$67.69 - $73.03 $16,448 - $17,746
243 Added 1.66%
14,908 $1.04 Million
Q2 2021

Jul 11, 2022

BUY
$63.47 - $69.35 $281,743 - $307,844
4,439 Added 43.41%
14,665 $1.01 Million
Q1 2021

Jul 11, 2022

BUY
$60.0 - $68.46 $613,560 - $700,071
10,226 New
10,226 $661,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Range Financial Group LLC Portfolio

Follow Range Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Range Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Range Financial Group LLC with notifications on news.